MAP2 Knockout HAP1 Cell Line

Important clarification: MAP2 (microtubule-associated protein 2) is a structural/scaffolding protein, NOT a kinase, despite the 'MAP' prefix that is also used in 'MAP kinase' (MAPK) nomenclature. MAP2 belongs to the microtubule-associated protein family (with MAP1A, MAP1B, MAP4, tau/MAPT) that binds and stabilizes microtubules. The choice between knockout and overexpression depends on whether you are studying MAP2's role in microtubule stabilization, dendrite morphology, or as a neuronal marker. The Knockout line is the standard tool for asking whether MAP2 is required for dendrite-specific microtubule stabilization — MAP2 is highly enriched in neuronal dendrites and is one of the most widely used dendrite markers in neuroscience research. Important consideration: MAP2 is principally expressed in neurons (and is a defining marker of neuronal differentiation) — HAP1 is not the physiological context for canonical MAP2 functions. The EDITGENE MAP2 Knockout in HAP1 is most useful for biochemistry, heterologous expression studies, and as a clean genetic background for MAP2 structure-function research. Rescue with wild-type MAP2 enables structure-function studies. For physiologically relevant MAP2 research, neuronal models (primary neurons, iPSC-derived neurons) are more appropriate.

Primary applications: • Heterologous microtubule stabilization: in vitro tubulin polymerization and microtubule stability assays using recombinant MAP2. • Structure-function studies: rescue with wild-type or microtubule-binding-deficient MAP2 in clean genetic background. • Neuronal differentiation marker validation: critical specificity control for anti-MAP2 antibodies used in neuronal identification. • Splice isoform studies: MAP2 has multiple splice isoforms (MAP2a, MAP2b, MAP2c, MAP2d) with developmental and tissue-specific expression — rescue with specific isoforms enables isoform-function studies. EDITGENE recommends this model for in vitro MAP2 biochemistry; physiological dendritic MAP2 research requires neuronal models.

Yes. MAP2 rescue experiments require attention to splice isoform diversity: • Construct design: use a codon-modified MAP2 sequence with a small C-terminal tag (FLAG, HA). MAP2 has multiple isoforms (MAP2a/b — large dendritic; MAP2c — embryonic and adult brain; MAP2d) — choose the isoform appropriate to the experimental question. • Microtubule-binding-deficient rescue: microtubule-binding domain mutations (basic residue mutations in MT-binding region) abolish microtubule association and serve as the standard specificity control. • Phosphorylation-resistant rescue: phospho-site mutations (multiple PKA/MARK substrate sites) generate phosphorylation-resistant MAP2 for studying phosphorylation-dependent regulation. • Functional readout: rescue should restore microtubule stabilization in vitro and dendrite-like processes in heterologous contexts. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.